RESEARCH NEWS 2012-12-21 Research News The world did not end today as predicted, but unfortunately we have to report that development of another potential drug did. Allon Therapeutics Inc. announced 19 December that its drug candidate davunetide failed to show efficacy for progre
PAPER Follett J, Darlow B, Wong MB, Goodwin J, Pountney DL
Neurotox Res. 2012 Dec 19; PubMed: 23250862
PAPER Cao L, Li L, Lin D, Zuo Z
PLoS One. 2012;7(12):e51431. PubMed: 23251531
PAPER Gómez-Suaga P, Fdez E, Blanca Ramírez M, Hilfiker S
Parkinsons Dis. 2012;2012:324521. PubMed: 23251830
PAPER Yamashita T, Hideyama T, Hachiga K, Teramoto S, Takano J, Iwata N, Saido TC, Kwak S
Nat Commun. 2012;3:1307. PubMed: 23250437
PAPER Ching JK, Elizabeth SV, Ju JS, Lusk C, Pittman SK, Weihl CC
Hum Mol Genet. 2013 Mar 15;22(6):1167-79. PubMed: 23250913
PAPER Pacioni S, Rueger MA, Nisticò G, Bornstein SR, Park DM, McKay RD, Androutsellis-Theotokis A
PLoS One. 2012;7(12):e51630. PubMed: 23251599
PAPER Younesi E, Toldo L, Müller B, Friedrich CM, Novac N, Scheer A, Hofmann-Apitius M, Fluck J
BMC Med Inform Decis Mak. 2012;12:148. PubMed: 23249606
PAPER Agyare E, Leonard S, Curran G, Yu C, Lowe V, Paravastu AK, Poduslo J, Kandimalla KK
Mol Pharm. 2012 Dec 18; PubMed: 23249146
PAPER Rogers K, Felsenstein KM, Hrdlicka L, Tu Z, Albayya F, Lee W, Hopp S, Miller MJ, Spaulding D, Yang Z, Hodgdon H, Nolan S, Wen M, Costa D, Blain JF, Freeman E, De Strooper B, Vulsteke V, Scrocchi L, Zetterberg H, Portelius E, Hutter-Paier B, Havas D, Ahlijanian M, Flood D, Leventhal L, Shapiro G, Patzke H, Chesworth R, Koenig G
Mol Neurodegener. 2012;7:61. PubMed: 23249765
PAPER Crenshaw DG, Gottschalk WK, Lutz MW, Grossman I, Saunders AM, Burke JR, Welsh-Bohmer KA, Brannan SK, Burns DK, Roses AD
Clin Pharmacol Ther. 2013 Feb;93(2):177-85. PubMed: 23249780
PAPER Wang Q, Wang C, Zuo Y, Wang Z, Yang B, Kuang H
Molecules. 2012;17(12):15013-21. PubMed: 23250029